MERCK Kommanditgesellschaft auf Aktien (MRK.XETRA)
Exchange: XETRA
Currency: EUR
Price: 188.95 (Close)
Summary
| 52 Week range | 200d Moving Avg. | Beta |
| 134.50 – 231.50 | 192.90 | 0.53 |
| Dividend | Dividend Yield | Ex-Dividend date |
| 1.85 | 0.98% | 2022-04-25 |
| P/E Ratio | Latest EPS | DGR 3 years |
| 26.89 | 7.03 | 3.85% |
Overvalued
Low
Low Volatility
High
Slow
Dividend Growth
Fast
Profile
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc.; a collaboration with Daiichi Sankyo Company, Limited; a co-development agreement with Oncolytics Biotech Inc.; a partnership with GlucoMe LTD; and collaboration agreements with Phosplatin Therapeutics LLC and Vyriad Inc. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
| Sector: | Industry: | |
| Healthcare | Drug Manufacturers—Specialty & Generic | |
Total ESG Score
17 – 19 percentile
Environment
2 – 1 percentile
Social
10 – 1 percentile
Governance
6 – 1 percentile
Controversy level
2
MSCI ESG-Rating
n.a.
see MSCI ESG rating explained
Dividend Safety Metrics
| Latest EPS | 7.03 | |
| Annual Payout | 1.85 | |
| Payout Ratio | 26.32% | |
| Dividend growth | 2 Years | |
| Dividend Score | 0 | |
| Dividend Coverage Ratio | 3.80 | |
| Altman-Z score | 0.00 |
MERCK Kommanditgesellschaft auf Aktien (MRK.XETRA) Valuation
MERCK Kommanditgesellschaft auf Aktien current dividend yield of 0.98% is -10% below its 5-year average. The 5-year average dividend yield is 1.09% (see red-line in chart). This indicates the stock looks overvalued today.
MERCK Kommanditgesellschaft auf Aktien (MRK.XETRA) Performance
The chart below displays the total price return(%) of MERCK Kommanditgesellschaft auf Aktien for different periods:
MERCK Kommanditgesellschaft auf Aktien (MRK.XETRA) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of MERCK Kommanditgesellschaft auf Aktien for different periods:
Dividend Scorecard
| Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
| 0.98 | 1.85 | 26.32% | 2 Years |
Dividend Growth Summary
| 3 Year Growth Rate (CAGR) | 3.85% |
| 5 Year Growth Rate (CAGR) | 5.92% |
| 10 Year Growth Rate (CAGR) | 1.14% |
Dividend Growth Rates History
| Year | Payout Amount | Annual Payout Growth (YoY) |
|---|---|---|
| 2021 | 1.400 | 7.7% |
| 2020 | 1.300 | 4.0% |
| 2019 | 1.250 | 0.0% |
| 2018 | 1.250 | 4.2% |
| 2017 | 1.200 | 14.3% |
| 2016 | 1.050 | 5.0% |
| 2015 | 1.000 | -47.4% |
| 2014 | 1.900 | 11.8% |
| 2013 | 1.700 | 13.3% |
| 2012 | 1.500 | 20.0% |
| 2011 | 1.250 | 25.0% |
| 2010 | 1.000 | -33.3% |
| 2009 | 1.500 | 25.0% |
| 2008 | 1.200 | 33.3% |
MERCK Kommanditgesellschaft auf Aktien (MRK.XETRA) Dividend Payment History